• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Pharming Group News

    0,8995 € +1,07% +0,0095 €
    26.04.24 19:37:45 Tradegate aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1H65A
    ISIN: NL0010391025
    US-Symbol: PHGUF
    Typ: Aktie

    Pharming Group News

    24.04.24 - GlobeNewswire
    Pharming Group to report first quarter 2024 financial results on May 8
    Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first ...
    19.04.24 - GlobeNewswire
    Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
    NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH ...
    18.04.24 - GlobeNewswire
    Pharming Group announces the placement of €100 million convertible bonds due 2029
    NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH ...
    18.04.24 - GlobeNewswire
    Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
    NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH ...
    29.02.24 - GlobeNewswire
    Pharming Group to report fourth quarter and full year 2023 financial results on March 14
    Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) ...
    08.02.24 - GlobeNewswire
    Pharming Group to participate in February investor conferences
    Leiden, The Netherlands, February 8, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will ...
    01.11.23 - GlobeNewswire
    Pharming Group to participate in November investor conferences
    Leiden, The Netherlands, November 1, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will ...
    26.10.23 - GlobeNewswire
    Pharming Group reports third quarter 2023 financial results
    Pharming Group reports third quarter 2023 financial results
    12.10.23 - GlobeNewswire
    Pharming Group to report third quarter 2023 financial results on October 26
    Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third ...
    25.09.23 - GlobeNewswire
    Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
    Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary ...
    09.08.23 - DGAP
    Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
    Original-​Research: Pharming Group NV - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Pharming Group NV Unternehmen ...
    18.07.23 - DGAP
    Original-Research: Pharming (von First Berlin Equity Research GmbH): Buy
    Original-​Research: Pharming - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Pharming Unternehmen: Pharming ISIN ...
    13.03.23 - PR Newswire
    Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement
    Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement PR Newswire
    22.02.23 - PR Newswire
    Pharming gibt Aufnahme des ersten Patienten an der pädiatrischen klinischen Studie mit Leniolisib bekannt
    Pharming gibt Aufnahme des ersten Patienten an der pädiatrischen klinischen Studie mit Leniolisib bekannt PR Newswire
    21.02.23 - PR Newswire
    Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
    Pharming announces first patient enrolled in pediatric clinical trial of leniolisib PR Newswire
    21.02.23 - PR Newswire
    Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
    Pharming announces first patient enrolled in pediatric clinical trial of leniolisib PR Newswire
    03.11.22 - PR Newswire
    Pharming to present at Jefferies Healthcare Conference
    Pharming to present at Jefferies Healthcare Conference PR Newswire
    29.10.22 - PR Newswire
    Pharming gibt bekannt, dass die Europäische Arzneimittelagentur (EMA) ihren Zulassungsantrag im Rahmen einer beschleunigten Bewertung für Leniolisib validiert hat
    Pharming gibt bekannt, dass die Europäische Arzneimittelagentur (EMA) ihren Zulassungsantrag im Rahmen einer beschleunigten Bewertung für Leniolisib validiert hat PR Newswire
    28.10.22 - PR Newswire
    Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
    Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib PR Newswire
    12.10.22 - PR Newswire
    Pharming Group Notice of Q3 Results
    Pharming Group Notice of Q3 Results PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »